EDUARDO AGÜERA MORALESBEGOÑA MARIA ESCRIBANO DURÁNEVELIO FRANCISCO LUQUE CARABOT2026-01-292026-01-29201610.2174/13816128226661607080004532-s2.0-85031758795https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28516Drug DiscoveryPharmacologyDrug DiscoveryPharmacologyNatalizumab modifies catecholamines levels present in patients with relapsing-remitting multiple sclerosisresearch article